Psyched Wellness Submits Trademark For Amanita Muscaria Extract
Psyched Wellness (CSE: PSYC) is looking to build up its portfolio of intellectual property. The company this morning announced that it has submitted an application to register a trademark for the unique extraction process that it has developed.
The company is looking to register the trademark “AME-1”, which stands for Amanita Muscaria Extract-1. The trademark is related to the unique extract that the company developed after a long process of trial and error, resulting in the creation of the ideal extract for future products.
More specifically, Psyched Wellness this morning outlined that it was able to finalize the extraction process after it developed a high performance liquid chromatography analytical method for the unique compounds and raw material within Amanita Muscaria. As a result, AME-1 is to be the base for future product lines created in the health and wellness space.
Going forward, the company intends to build a patent portfolio around AME-1 for optimized psychedelic medicines.
Psyched Wellness last traded at $0.35 on the CSE.
FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
